Herring Bradley's Form 4 filing
Enfusion, Inc. (ENFN) · filed Dec 26, 2024
- Accession no.
- 0001104659-24-131717
- Filed
- Dec 26, 2024
- Trade date
- Dec 20, 2024
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $259.3K. It was filed 6 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Herring BradleyCIK 0001813901 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | Class A Common Stock | SSaleDisposed | −24,443 | $10.61F2 | −$259,340.23 | 270,503 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.32 to $10.74. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.